CMS Proposes Compendia Publish All Materials Related To Listing Decision
Executive Summary
In an effort to increase the transparency in the compendia listing process, CMS is proposing that approved compendia publish all materials used in evaluating an off-label usage of a drug
You may also be interested in...
HHS OIG To Investigate Drug Shortages, Rebates, Other Pharma Issues In 2013
A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.
Zevalin Completes Transition To ASP-Based Reimbursement In OPPS
Spectrum Pharmaceuticals' radiopharmaceutical Zevalin (ibritumomab tiuxetan) will be reimbursed like other Medicare Part B drugs administered in the hospital outpatient setting, according to the final outpatient prospective payment update for 2010
Zevalin Completes Transition To ASP-Based Reimbursement In OPPS
Spectrum Pharmaceuticals' radiopharmaceutical Zevalin (ibritumomab tiuxetan) will be reimbursed like other Medicare Part B drugs administered in the hospital outpatient setting, according to the final outpatient prospective payment update for 2010